139 related articles for article (PubMed ID: 17348877)
1. Measures to prevent TRALI.
Wendel S; Biagini S; Trigo F; Fontão-Wendel R; Taaning E; Jørgensen J; Riisom K; Krusius T; Koskinen S; Kretschmer V; Karger R; Lawlor E; Okazaki H; Charlewood R; Brand A; Solheim BG; Flesland O; Letowska M; Zupanska B; Muñiz-Diaz E; Nogués N; Senn M; Mansouri-Taleghani B; Chapman CE; Massey E; Navarrete C; Stainsby D; Win N; Williamson LM; Kleinman S; Kopko PM; Silva M; Shulman I; Holness L; Epstein JS
Vox Sang; 2007 Apr; 92(3):258-77. PubMed ID: 17348877
[No Abstract] [Full Text] [Related]
2. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
4. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
5. Implementation of a strategy to prevent TRALI in a regional blood centre.
Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
[TBL] [Abstract][Full Text] [Related]
6. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
[TBL] [Abstract][Full Text] [Related]
7. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
Sachs UJ; Kauschat D; Bein G
Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of TRALI: current concepts.
Sachs UJ
Intensive Care Med; 2007 Jun; 33 Suppl 1():S3-S11. PubMed ID: 17676436
[TBL] [Abstract][Full Text] [Related]
9. [Communications by the Blood Working Group of the Federal Public Health Administration. Measures to prevent transfusion-induced lung failure (TRALI)].
Burger R; Offergeld R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 May; 52(5):572. PubMed ID: 19407940
[No Abstract] [Full Text] [Related]
10. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI).
Mair DC; Hirschler N; Eastlund T
Crit Care Med; 2006 May; 34(5 Suppl):S137-43. PubMed ID: 16617258
[TBL] [Abstract][Full Text] [Related]
11. Progress in TRALI.
Wallis JP
Transfus Med; 2008 Oct; 18(5):273-5. PubMed ID: 18937732
[No Abstract] [Full Text] [Related]
12. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
[TBL] [Abstract][Full Text] [Related]
13. [TRALI].
Muller JY
Transfus Clin Biol; 2005 Jun; 12(2):230-5. PubMed ID: 15925530
[No Abstract] [Full Text] [Related]
14. A touch of TRALI.
Davis A; Mandal R; Johnson M; Makar R; Stowell C; Dzik S
Transfusion; 2008 Mar; 48(3):541-5. PubMed ID: 18067496
[TBL] [Abstract][Full Text] [Related]
15. Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS).
Triulzi DJ; Kakaiya R; Schreiber G
Transfusion; 2007 Apr; 47(4):563-4. PubMed ID: 17381611
[No Abstract] [Full Text] [Related]
16. Transfusion-related acute lung injury (TRALI): presentation, epidemiology and treatment.
Wallis JP
Intensive Care Med; 2007 Jun; 33 Suppl 1():S12-6. PubMed ID: 17676434
[No Abstract] [Full Text] [Related]
17. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
[TBL] [Abstract][Full Text] [Related]
19. The impact of screening a platelet donor panel for human leucocyte antigen antibodies to reduce the risk of transfusion-related acute lung injury.
Boulton-Jones R; Norris A; O'Sullivan A; Comrie A; Forgan M; Rawlinson PS; Clark P
Transfus Med; 2003 Jun; 13(3):169-70. PubMed ID: 12791086
[No Abstract] [Full Text] [Related]
20. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
